Novel Biomaterials for Tissue Engineering and Regenerative Medicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 1563
Special Issue Editors
2. Department of Pharmaceutics, Faculty of Pharmacy and Drug Technology, The Egyptian Chinese University, Cairo 11786, Egypt
Interests: nanotechnology as drug delivery systems to protein delivery; phytomedicine; tissue regeneration; application of photodynamic therapy
Special Issue Information
Dear Colleagues,
In this Special Issue of Pharmaceutics: “Novel Biomaterials for Tissue Engineering and Regenerative Medicine”, an array of recent developments in fabrication methods of biomaterials and implants in tissue engineering, wound healing and bone regeneration are discussed. Novel biomaterials outperform conventional substrates in terms of tissue compatibility and safety. Novel biomaterials, spanning from nanofibrous scaffolds to metallic-based implants or a mixture of elements as nano-clays, have exhibited encouraging results in recent studies. The use of novel biomaterials in tissue regeneration is such a hot topic that led to the shift and attention of the research to this field. The ability to heal fast has always been a trait of Superheros, but the use of novel and safe biomaterials in tissue regeneration is making this dream a reality for normal people. In addition, the success of the earlier Pharmaceutics Special Issue: “Novel Nano-Engineered Biomaterials for Bone Tissue Engineering” led to the dedication of another Special Issue in this field on a broader tissue level. The application of novel biomaterials in tissue engineering and regenerative medicine with the associated fast technology transfer will be the focus of this Special Issue.
Prof. Dr. Aliaa N. ElMeshad
Dr. Dina B. Mahmoud
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- scaffold
- nanofibers
- hydrogels
- implantable
- in situ
- nanoclay
- biocompatibility
- tissue engineering
- wound healing
- regenerative medicine